ICSS for Assessing the Abuse Potential of Psychedelics

Tryp Therapeutics Announces Amendment to Option Plan and Option Grant

PTSF53 – Psychedelics and Creativity, with Laura Dawn

COMPASS Pathways appoints Wayne J Riley MD to its Board of...

Tryp Therapeutics Appoints Greg McKee as Chief Executive Officer

9 Women of Color Creating A More Inclusive Psychedelic Movement

Lobe Sciences Becomes Enterprise Member of NFL Alumni Association

Wesana Health Announces Closing of C$16.1 Million Oversubscribed Private Placement

MINDCURE Files Provisional Patent Application For iSTRYM, its Proprietary AI Digital...

Nova Mentis Establishes Serotonin Research Centre

Load more